Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Jazz Pharmaceuticals plc (Nasdaq: JAZZ)

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain, psychiatry and women's health. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate), Erwinaze™ (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide intrathecal infusion), FazaClo® (clozapine USP) HD and LD, Luvox CR® (fluvoxamine maleate) and Elestrin® (estradiol gel 0.06%). Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by an international division, EUSA Pharma. *

 

Period Start 2012-06-12 existent
Product Industry pharmaceutical
Person Person Cozadd, Bruce (Jazz Pharmaceuticals 201312 CEO)
     
Region Region Dublin
  Country Ireland, Republic of
  Street One Burlington Road
Fourth Floor, Connaught House
  City Dublin 4
  Tel +353-1-634-7800
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2021-02-05

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Jazz Pharmaceuticals plc (Nasdaq: JAZZ)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top